dandelion
Taraxacum is a genus of flowering plants in the family Asteraceae, which consists of species commonly known as dandelions. The scientific and hobby study of the genus is known as taraxacology. The genus has a near-cosmopolitan distribution, absent only from tropical and polar areas. Two of the most common species worldwide, T. officinale and T. erythrospermum, are European species introduced into North America, where they are non-native. Dandelions thrive in temperate regions and can be found in yards, gardens, sides of roads, among crops, and in many other habitats. — Wikipedia
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Earliest trial started Oct 1, 2011 (NCT01135784)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
Unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaTaraxacum ↗
Also known as
- dandelion
- dandelion
- taraxaci
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01135784 | Phase 2 | Oct 1, 2011 | RZN Nutraceuticals, Inc., Tel Aviv University |
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| RZN Nutraceuticals, Inc. | For profit | 1 | 1 | 1 | 2011 |
| Tel Aviv University | Academic/Hospital | 1 | 0 | 1 | 2011 |